Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment

BACKGROUND/AIMS: Disease-modifying therapy for Alzheimer's disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD. METHODS: We assessed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dement Geriatr Cogn Dis Extra
Hauptverfasser: Park, Jung Eun, Choi, Kyu Yeong, Kim, Byeong C., Choi, Seong-Min, Song, Min-Kyung, Lee, Jang Jae, Kim, Jahae, Song, Ho-Chun, Kim, Hoo-Won, Ha, Jung-Min, Seo, Eun Hyun, Song, Woo Keun, Park, Sung-Gyoo, Lee, Jung Sup, Lee, Kun Ho
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2019
Schlagworte:
Original Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465729/
https://ncbi.nlm.nih.gov/pubmed/31011328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496920
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge